BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $11.73 million. The enterprise value is $2.85 million.

Market Cap	11.73M
Enterprise Value	2.85M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BRTX has 7.98 million shares outstanding. The number of shares has increased by 65.13% in one year.

Current Share Class	7.98M
Shares Outstanding	7.98M
Shares Change (YoY)	+65.13%
Shares Change (QoQ)	+2.85%
Owned by Insiders (%)	18.03%
Owned by Institutions (%)	3.63%
Float	5.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.40
Forward PS	6.54
PB Ratio	1.84
P/TBV Ratio	2.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24

Current Ratio	2.24
Quick Ratio	2.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -117.16% and return on invested capital (ROIC) is -73.74%.

Return on Equity (ROE)	-117.16%
Return on Assets (ROA)	-54.16%
Return on Invested Capital (ROIC)	-73.74%
Return on Capital Employed (ROCE)	-199.41%
Revenue Per Employee	$35,545
Profits Per Employee	-$1.10M
Employee Count	11
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.90% in the last 52 weeks. The beta is 76.33, so BRTX's price volatility has been higher than the market average.

Beta (5Y)	76.33
52-Week Price Change	+4.90%
50-Day Moving Average	1.62
200-Day Moving Average	1.71
Relative Strength Index (RSI)	46.90
Average Volume (20 Days)	64,657

Short Selling Information

The latest short interest is 155,518, so 1.95% of the outstanding shares have been sold short.

Short Interest	155,518
Short Previous Month	171,252
Short % of Shares Out	1.95%
Short % of Float	2.88%
Short Ratio (days to cover)	1.58

Income Statement

In the last 12 months, BRTX had revenue of $391,000 and -$12.10 million in losses. Loss per share was -$1.48.

Revenue	391,000
Gross Profit	360,019
Operating Income	-12.25M
Pretax Income	-6.96M
Net Income	-12.10M
EBITDA	-12.06M
EBIT	-12.25M
Loss Per Share	-$1.48

Balance Sheet

The company has $9.11 million in cash and n/a in debt, giving a net cash position of $9.11 million or $1.14 per share.

Cash & Cash Equivalents	9.11M
Total Debt	n/a
Net Cash	9.11M
Net Cash Per Share	$1.14
Equity (Book Value)	6.14M
Book Value Per Share	0.82
Working Capital	5.17M

Cash Flow

In the last 12 months, operating cash flow was -$8.69 million and capital expenditures -$142,589, giving a free cash flow of -$8.83 million.

Operating Cash Flow	-8.69M
Capital Expenditures	-142,589
Free Cash Flow	-8.83M
FCF Per Share	-$1.11

Margins

Gross Margin	92.08%
Operating Margin	-3,133.88%
Pretax Margin	-3,093.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.13%
Shareholder Yield	-65.13%
Earnings Yield	-101.08%
FCF Yield	-73.82%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	256.89%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	1:4,000

Scores

BRTX has an Altman Z-Score of -23.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.49
Piotroski F-Score	2